Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;143(10):1941-1946.
doi: 10.1007/s00432-017-2444-0. Epub 2017 May 24.

Analysis of primary-miRNA-3662 and its mature form may improve detection of the lung adenocarcinoma

Affiliations

Analysis of primary-miRNA-3662 and its mature form may improve detection of the lung adenocarcinoma

Tomasz Powrózek et al. J Cancer Res Clin Oncol. 2017 Oct.

Abstract

Introduction: Because of the alarming data concerning lung cancer morbidity and mortality, investigation of new molecular markers allowing early cancer detection is desirable. In the present study, we investigated the potential role of miRNA-3662 precursor (pri-miRNA-3662) as potential novel diagnostic marker of lung adenocarcinoma (AC).

Materials and methods: Expression of miRNA-3662 and pri-miRNA-3662 was analyzed in 56 fresh-frozen tissues of non-small cell lung cancer and corresponding adjacent non-cancerous tissues using (NCT) qRT-PCR. Using receiver operating curves (ROC) analysis, the diagnostic accuracy of both studied markers for AC detection was assessed.

Results: miRNA-3662 and its precursor were significantly overexpressed in AC compared to squamous-cell carcinoma (SCC) and NCT. Combined analysis of pri-miRNA-3662 and mature miRNA-3662 allowed to distinguish AC tissue from SCC with sensitivity of 96% and specificity of 85.7% (AUC = 0.963), and SCC from non-cancerous tissue with 92% sensitivity and 92% specificity (AUC = 0.979).

Conclusions: miRNA-3662 and its precursor are potentially involved in AC development. pri-miRNA seem to be novel interesting group of potential cancer biomarkers, because they demonstrate high diagnostic accuracy for tumor detection.

Keywords: Adenocarcinoma; Lung cancer; miRNA; pri-miRNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Differences in expression of pri-miRNA-3662 and miRNA-3662 in adenocarcinoma (AC), squamous-cell carcinoma (SCC) and non-cancerous (NT) tissues
Fig. 2
Fig. 2
a Relative expression level of pri-miRNA-3662 in all AC samples and in corresponding adjacent non-cancerous tissues (NCT); b differences in pri-miRNA-3662 expression between AC and NCT: box and whisker represent median (band inside the box) and interquartile range (1st and 3rd quartile), whereas ends of the whiskers present minimal and maximal expression of studied samples; c relative expression level of miRNA-3662 in all AC samples and in corresponding NCT samples; d differences in miRNA-3662 expression between AC and NCT: box and whisker interpreted as in b
Fig. 3
Fig. 3
Diagnostic accuracy of studied AC markers conducted by ROC analysis with AUC calculation: a combined analysis of pri-miRNA-3662 and miRNA-3662 and their diagnostic accuracy for distinguishing AC from SCC; b combined analysis of pri-miRNA-3662 and miRNA-3662 and their diagnostic accuracy for distinguishing ACC from NCT

References

    1. Bach PB, Mirkin JN, Oliver TK et al (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307:2418–2429 - DOI - PMC - PubMed
    1. Bianchi F, Nicassio F, Marzi M et al (2011) A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med 3(8):495–503 - DOI - PMC - PubMed
    1. Chang TC, Pertea M, Lee S et al (2015) Genome-wide annotation of microRNA primary transcript structures reveals novel regulatory mechanisms. Genome Res 25(9):1401–1409 - DOI - PMC - PubMed
    1. Dela Cruz CS, Tanoue LT, Matthay RT (2011) Lung cancer: epidemiology, etiology and prevention. Clin Chest Med 32(4):605–644 - DOI - PMC - PubMed
    1. Di Leva G, Garofalo M, Croce CM (2014) MicroRNAs in cancer. Annu Rev Pathol 9:287–314 - DOI - PMC - PubMed